Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke "GDPRS"

Not yet recruiting

Phase 2/3 Results N/A

Summary of Purpose

This study evaluates the addition of Ginkgo Diterpene Lactone Meglumine Injection to aspirin in the treatment of acute ischemic stroke.Half of patient will receive Ginkgo Diterpene Lactone Meglumine Injection(25mg once/day D1-D14) and aspirin(300mg loading dose,then 100mg once/day D2-D14) in combination, while the other half will receive aspirin(300mg loading dose,then 100mg once/day D2-D14).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 July 2017.

15 Jul 2017 5 Jul 2017 31 Oct 2017 31 Dec 2017 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

Not available